The UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (UK CERSI-PGx), led by the University of Liverpool, has published its first clinical guideline focused on […]
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors—such as empagliflozin (Jardiance) and dapagliflozin (Farxiga)—or glucagon-like peptide-1 (GLP-1) […]
Long-term antidepressant use in Australia has risen steadily over the past decade, with the largest increase seen in young people aged 10-24, where rates have more than doubled. […]
Clinicians may fail to recognize common side effects of drugs like gabapentin — which are frequently prescribed for nerve pain — leading them to prescribe unnecessary medications that […]
Multiple pre-exposure (PrEP) and postexposure (PEP) treatments are now available to prevent HIV infection. An updated Canadian guideline published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.250511 contains 31 recommendations and 10 good practice […]
New research reveals that more than 7 in 10 (71%) women have consumed alcohol-free or low-alcohol drinks during pregnancy, signalling their growing popularity among expectant mothers seeking safer […]
Some blood pressure medications can make the skin extra prone to sunburn. A registry study from Lund University in Sweden shows a possible increased risk of basal cell […]
Adult acne is more common than often assumed. According to research from the University of Oulu, around 31 per cent of 35-year-old Finnish women have acne on the […]
A rigorous systematic review of the use of paracetamol (also known as acetaminophen) during pregnancy has found that the common painkiller does not increase the risk of specific […]
A severe form of nausea that occurs during pregnancy is linked to depression, according to a study conducted at the University of Turku in Finland. Researchers found that […]
The EU drug watchdog, the European Medicines Agency (EMA), has launched a partnership with social media influencers to promote the safe use of GLP-1 receptor agonists. The #HealthNotHype […]
In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 medications before or early in their pregnancy tended to gain […]
ADVERTISMENT
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.
